U.K. authority slaps Merck for Januvia promos; Abbott cuts formula prices amid Chinese probe;

@FiercePharma: Investors hiss at Pharmstandard spinoff engineering. Plans to buy out investors who oppose OTC deal--at a discount. More | Follow @FiercePharma

 @CarlyHFierce: Alleged Botox marketing strategy in China named for Russian sniper Vasily Zaytsev - anyone seen Enemy at the Gates? More (sub. req.) | Follow @CarlyHFierce

> Merck's ($MRK) unit in the U.K. was censured by the Prescription Medicines Code of Practice Authority for infringing its marketing code with its Januvia promotions. Report

> Amid a pricing probe in China, Abbott Laboratories ($ABT) cut the prices on its infant formula sold there by up to 12%. Report

> Chile's CFR Pharmaceuticals says that, after buying South Africa's Adcock Ingram, it would list the combined company's shares on the Johannesburg Stock Exchange. Report

> The General Court of the European Union tossed out a 2011 decision to deny marketing approval to Laboratoires CTRS' orphan drug Orphacol. Report

> Novartis ($NVS) tapped Insight Public Affairs to handle its corporate and brand communications with the government, to promote the pharma industry's role in the U.K. economy. Report

> The market for dry-eye treatments is growing as more people develop the syndrome, partly because of increased use of computers, tablets and smartphones. Report

Medical Device News

@FierceMedDev: New special report: A look at 2013's hot M&A start. Feature | Follow @FierceMedDev

 @MarkHFierce: It's not easy for Dx outfits to win Medicare coverage in today's market, but Crescendo did. Story | Follow @MarkHFierce

@DamianFierce: Are Intuitive's weak da Vinci sales a hiccup or an omen? Shares slipped 15% overnight. News | Follow @DamianFierce

> Diagnostic device detects bladder cancer through urine odor. Article

> Tyrx gains FDA clearance for dissolvable antibacterial envelope. Story

> Denmark wants EU ban on chemical used in device manufacturing. More

Biotech News

@FierceBiotech: 'Fraud' found at China site for key study of Pfizer and Bristol's Eliquis. Report | Follow @FierceBiotech

 @JohnCFierce: Amgen commits $50M-plus in 3-way deal to expand cardiovascular drug pipeline. Article | Follow @JohnCFierce

@RyanMFierce: Expert exposes "highly questionable" data from biotech Cardio3 after IPO. ICYMI yesterday | Follow @RyanMFierce

> UniQure snags $58M in collaboration cash plus equity. Item

> Forma enlists expert partners to create a portfolio of virtual cancer biotechs. Report

> GlaxoSmithKline teams with Immunocore on next-gen cancer immunotherapies. News

Pharma Manufacturing News

 @EricPFierce: I'm looking for pharma folks interested in being part of a webinar on how their companies are using marketing apps to talk with clients. Let me know. | Follow @EricPFierce

> Nikkei: Teva to double manufacturing capacity in Japan. More

> Wockhardt faces 2nd import alert. Report

> Hikma New Jersey plant back in production. Article

> Fresenius gets 2nd warning letter in 18 months. Story

Biotech Research News

 @EmilyMFierce: Ohio-based startup Biosortia is tapping into nature to fill early drug-discovery void. Editor's corner | Follow @EmilyMFierce

> U.K. launches large-scale genomics project. More

> Immune modulation could explain how experimental Alzheimer's therapy works. Item

> More positive preclinical results for Inovio's H7N9 vaccine. Story

> New research could help cut cardiovascular risks associated with arthritis drugs. Article

And Finally... Who needs a pill when they have a pencil? Drawing pictures of comfort food can ease cravings, study finds. Report